Table 4 Descriptive statistics and Shapiro–Wilk test results for quantitative variables in the patients who underwent Ilizarov treatment with no compression, n = 38).
M | Me | SD | Sk | Kurt | Min | Max | S–W | p-value | |
|---|---|---|---|---|---|---|---|---|---|
Length of hospital stay (days) | 15.34 | 11.00 | 10.61 | 1.21 | 0.22 | 4.00 | 39.00 | 0.81 | < 0.001 |
Ilizarov treatment duration (days) | 255.03 | 204.00 | 155.94 | 1.90 | 3.92 | 84.00 | 810.00 | 0.80 | < 0.001 |
ASAMI bone score | 8.68 | 10.00 | 3.09 | − 2.00 | 2.21 | 0.00 | 10.00 | 0.45 | < 0.001 |
ASAMI functional score | 5.16 | 6.00 | 1.28 | − 1.93 | 5.42 | 0.00 | 6.00 | 0.63 | < 0.001 |
Number of complications | 0.32 | 0.00 | 0.53 | 1.40 | 1.13 | 0.00 | 2.00 | 0.61 | < 0.001 |
